It has been a busy time for us here at SPARK Impact as we recently made our 101st transaction via the North West Fund for Biomedical into up and coming healthcare companies.
Since the start of December, we have committed a further £1.4m in follow on funding to existing portfolio companies. We have also invested more than £300,000 into pioneering and high growth new companies developing innovative services and technologies.
With offices at Liverpool Science Park and BioHub at Alderley Park, we have now invested more than £24.5m of our £30m allocation.